Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD

Direct healthcare costs for patients with asthma are less than half (−52%) and for patients with COPD are 41% higher if compared to those of patients with bronchiectasis. The leading expense items in bronchiectasis are hospitalisations and antibiotics. https://bit.ly/3Iq8AUP

Detalles Bibliográficos
Autores principales: Ronco, Raffaella, Franco, Giovanni, Monzio Compagnoni, Matteo, Aliberti, Stefano, Luppi, Fabrizio, Corrao, Giovani, Faverio, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388176/
https://www.ncbi.nlm.nih.gov/pubmed/37529638
http://dx.doi.org/10.1183/23120541.00158-2023
_version_ 1785082054623363072
author Ronco, Raffaella
Franco, Giovanni
Monzio Compagnoni, Matteo
Aliberti, Stefano
Luppi, Fabrizio
Corrao, Giovani
Faverio, Paola
author_facet Ronco, Raffaella
Franco, Giovanni
Monzio Compagnoni, Matteo
Aliberti, Stefano
Luppi, Fabrizio
Corrao, Giovani
Faverio, Paola
author_sort Ronco, Raffaella
collection PubMed
description Direct healthcare costs for patients with asthma are less than half (−52%) and for patients with COPD are 41% higher if compared to those of patients with bronchiectasis. The leading expense items in bronchiectasis are hospitalisations and antibiotics. https://bit.ly/3Iq8AUP
format Online
Article
Text
id pubmed-10388176
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-103881762023-08-01 Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD Ronco, Raffaella Franco, Giovanni Monzio Compagnoni, Matteo Aliberti, Stefano Luppi, Fabrizio Corrao, Giovani Faverio, Paola ERJ Open Res Research Letters Direct healthcare costs for patients with asthma are less than half (−52%) and for patients with COPD are 41% higher if compared to those of patients with bronchiectasis. The leading expense items in bronchiectasis are hospitalisations and antibiotics. https://bit.ly/3Iq8AUP European Respiratory Society 2023-07-31 /pmc/articles/PMC10388176/ /pubmed/37529638 http://dx.doi.org/10.1183/23120541.00158-2023 Text en Copyright ©The authors 2023 https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org)
spellingShingle Research Letters
Ronco, Raffaella
Franco, Giovanni
Monzio Compagnoni, Matteo
Aliberti, Stefano
Luppi, Fabrizio
Corrao, Giovani
Faverio, Paola
Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD
title Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD
title_full Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD
title_fullStr Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD
title_full_unstemmed Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD
title_short Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD
title_sort healthcare costs and resource utilisation in bronchiectasis, asthma and copd
topic Research Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388176/
https://www.ncbi.nlm.nih.gov/pubmed/37529638
http://dx.doi.org/10.1183/23120541.00158-2023
work_keys_str_mv AT roncoraffaella healthcarecostsandresourceutilisationinbronchiectasisasthmaandcopd
AT francogiovanni healthcarecostsandresourceutilisationinbronchiectasisasthmaandcopd
AT monziocompagnonimatteo healthcarecostsandresourceutilisationinbronchiectasisasthmaandcopd
AT alibertistefano healthcarecostsandresourceutilisationinbronchiectasisasthmaandcopd
AT luppifabrizio healthcarecostsandresourceutilisationinbronchiectasisasthmaandcopd
AT corraogiovani healthcarecostsandresourceutilisationinbronchiectasisasthmaandcopd
AT faveriopaola healthcarecostsandresourceutilisationinbronchiectasisasthmaandcopd

Ejemplares similares